Abstract
Introduction

54
The skin of the majority of individuals with the inflammatory skin disease atopic dermatitis 55 (AD) is heavily colonised by Staphylococcus aureus (1). The healthy population has a much 56 lower rate of persistent carriage (~ 20%) and colonisation is usually confined to the nasal 57 cavity (2). S. aureus colonization of skin appears to post-date the development of AD, at 58 least in infant populations (3). In established AD the density of S. aureus on lesional and 59 non-lesional skin has a strong relationship to disease severity (4). A major risk factor for the 60 development of AD is loss-of-function mutations in the filaggrin (FLG) gene (5, 6) which 61 lead to a reduced level of natural moisturising factor (NMF) in the stratum corneum 62 accompanied by a skin epidermal barrier defect and an elevated pH (7). When the skin 63 barrier is compromised, factors produced by S. aureus exacerbate the symptoms of AD (8).
64
Several S. aureus factors have been linked to increased inflammation and disease severity in
65
AD including α-toxin (9), the staphylococcal superantigens (10) and δ-toxin (11).
66
S. aureus adheres to the cornified envelope of corneocytes in the stratum corneum.
67
Corneocytes from AD skin have an altered surface topology compared to corneocytes from anterior nares (14, 15) . ClfB and FnBPs are expressed at higher levels by bacteria grown in 78 vitro at the pH of AD skin than by bacteria grown at the low pH typical of healthy skin (16).
79
The binding of ClfB to its ligands is well understood at the molecular level. The X-ray crystal 80 structure of the ligand-binding region of ClfB has been solved both in the apo form and with 81 a peptide ligand bound (17). Binding occurs by the 'dock, lock and latch' mechanism 82 whereby a short peptide from loricrin or cytokeratin 10 binds to a hydrophobic trench located 83 between the separately folded N2 and N3 subdomains (18). A conformational change at the 84 C-terminus of N3 locks the ligand in place.
85
The aim of our study was to identify the bacterial factors that promote adherence of S.
86
aureus to corneocytes from AD skin. We studied clinically relevant strains of S. aureus from 
93
The ability of an AD strain and its isogenic ClfB-deficient mutant to adhere to corneocytes 94 from patients with AD was studied ex vivo and using atomic force microscopy (19). To collect AD strains, swabs were taken from a clinically infected site on the patient's skin 128 (Table S1) (1:1000) and bound antibody was detected using horseradish peroxidise-conjugated protein A
160
(1:500, Sigma). Reactive bands were visualised using the LumiGLO reagent and peroxide 
Downloaded from
Recombinant GST-tagged L2v was purified from E. coli as previously described (14) using a
166
GSTrap FF purification column (GE Healthcare) according to the manufacturer's instructions 167 and diluted in coating buffer (0.1 M NaHCO 3, 33 mM Na 2 CO 3, pH 9.6). Wells of a microtitre 168 plate (Nunc maxisorb) were incubated with a solution of L2v (0.625 µg/ml) overnight at 4°C.
169
Wells were blocked with bovine serum albumin (BSA, 5% (w/v)) for 2 h at 37°C. S. aureus 
209
The cantilevers spring constants were determined by the thermal noise method. For each 
Statistical Tests
250
Statistical significance was determined with the Student's t-test, using GRAPHPAD software. 
Results
252
Population structure of atopic dermatitis strains of S. aureus.
253
The skin of AD patients is frequently colonised by S. aureus. This study aimed to identify (Table S1 ). Molecular 258 typing methods were used to assign each strain to a clonal complex so that the general 259 population structure of the AD strains could be examined. The most common clonal complex
260
(CC) in the AD cohort was CC1 (9 isolates, 20.45%) followed by CC45 (7 isolates, 15.9%),
261
CC8 (6 isolates, 13.63%) and CC5 (6 isolates, 13.63%) (Fig. 1A) . Commensal S. aureus derived peptide fused to GST (Fig. 2) . The well characterised S. aureus strain SH1000 was 283 included as a control since adherence of SH1000 to L2v is solely dependent on ClfB (14) .
284
The amount of adherence for each clinical strain was expressed as a percentage of the 285 adherence value measured for SH1000. The commensal control strains were also tested.
286
Each data point in Fig. 2 in the stratum corneum of AD patients (Fig. 5) . In contrast, much fewer adhesion events with 343 a weaker strength (~200 pN) occurred with AD08 CC1 ∆clfB indicating that in the absence of 344 ClfB, S. aureus is less well able to adhere to corneocytes (Fig. 5) . Importantly, the number of All AD strains adhered to L2v and the median adherence level was high (Fig. 2B) .
351
ClfB is the only S. aureus factor that binds to L2v (Fig. 3, (14) . was carried out to allow visualisation of the position of the variant residues on the crystal 364 structure of ClfB N2N3 (Fig. 6A ). This indicated that the residues that vary between CC1 365 and CC30 are located well away from the trench between N2 and N3. Thus they are unlikely 366 to alter the affinity of ligand binding to the trench by the dock, lock and latch mechanism.
367
However it is possible that an additional, unknown ligand binding site could be located (Fig. 6) .
379
Previously the affinity of CC8 rClfB N2N3 for L2v was calculated to be 2.21 µM (14) . CC1 
396
Here we show that a clfB mutant bound significantly less strongly to corneocytes from two 
407
There were differences in the overall population structure of S. aureus strains from AD skin 408 lesions compared to strains isolated from a control population (commensal strains). This is 409 not entirely surprising given that the niche occupied by the bacteria is very different (AD skin 410 lesion versus nasal cavity). Nevertheless the control strains provided a useful comparison.
411
Since ClfB is a major determinant of nasal colonisation (14) it was surprising to find that aureus strain AD08 CC1 (1), its isogenic ClfB-deficient mutant AD08 CC1 ∆clfB (2) and 641 complemented mutant AD08 CC1 ∆clfB (pCU1::clfB) (3) were grown to exponential phase.
642
Cell wall extracts were separated on 7.5 % acrylamide gels, blotted onto PVDF membranes
643
and ClfB was detected using polyclonal rabbit antibodies. Bound antibody was detected 644 using horseradish peroxidise-conjugated protein A. Size markers (kDa) are indicated. 
